Mitchell Kapoor
Recent Articles
LA Biotech Unveils New Patented Nicotinamide Riboside Chloride 07/15/2024
"The advent of NIAGEN IV could usher in a powerful new tailwind for revenue growth at ChromaDex Corp. (CDXC:NASDAQ)," noted an H.C. Wainwright & Co. report.
Due to permission requirements, not all quotes are shown.
